Table: Taiko Pharmaceutical -2018/19 group results

Taiko Pharmaceutical

14/05/2019 07:00

May 14 (Reuters)- 
          Taiko Pharmaceutical Co Ltd 
          CONSOLIDATED FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)
                   Year ended      Year ended       Year to       NEXT   
                Mar 31, 2019    Mar 31, 2018   Mar 31, 2020     YEAR     
                   LATEST         YEAR-AGO        COMPANY      COMPANY   
                   RESULTS         RESULTS       FORECAST    H1 FORECAST 
  Sales             10.42           9.46           11.26                 
                 (+10.1 pct)     (+14.0 pct)    (+8.1 pct)               
  Operating          2.03           1.86            2.20                 
                 (+9.3 pct)      (+20.2 pct)    (+8.4 pct)               
  Recurring          1.89           1.57            1.95                 
                 (+20.2 pct)     (+11.4 pct)    (+3.4 pct)               
  Net
  Net                1.42           1.09            1.42                 
                 (+29.3 pct)     (+4.3 pct)     (+0.3 pct)               
  EPS             98.99 yen       77.38 yen      99.00 yen               
  EPS Diluted     98.88 yen       77.06 yen                              
  Ann Div         35.00 yen       25.00 yen      30.00 yen               
  -Q2 Div         10.00 yen          NIL         10.00 yen               
  -Q4 Div         25.00 yen       25.00 yen      20.00 yen               
  
  NOTE - Taiko Pharmaceutical Co Ltd.
  *Second Net profit row denotes profit attributable to owners ofthe parent 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4574.T